![]() |
|
REFERENCES: 1. 2. Slawinski M, Grodzinska L, Kostka-Trabka E, Bieron K, Goszcz A, Gryglewski RJ. L-Arginine - substrate for NO synthesis - its beneficial effects in therapy of patients with peripheral arterial disease: comparison with placebo - preliminary results. Acta Physiol Hung 1996; 84(4):457-8. 3. Visek WJ. Arginine needs, physiological state, and usual diets. J Nutr 1986;116:36-46. 4. Watanabe G, Tomiyama H, Doba N. Effects of oral administration of L-arginine on renal function in patients with heart failure. J Hypertens 2000 Feb;18(2):229-34. 5. Koifman B, Wollman Y, Bogomolny N, Chernichowsky T, Finkelstein A, Peer G, Scherez J, Blum M, Laniado S, 6. Rector TS, Bank AJ, Mullen KA, Tschumperlin LK, Sih R, Pillai K, Kubo SH. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. 7. Rector TS, Bunk AJ, Mullen KA et al. Randomized, double-blind, placebo-controlled study of 8. Hambrecht R, Fiehn E, Weigl C, et al. Regular physical exercise corrects endothelial dysfunction 9. Drexler H. Endothelial dysfunction. Prog Cardiovasc Dis 1997 Jan-Feb;39(4):287-324. 10. Hambrecht R, Hilbrich L, Erbs S, Gielen S, Fiehn E, Schoene N, Schuler G. Correction of 11. Bachmann S, Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. 12. Aiello S, Remuzzi G, Noris M. Nitric oxide/endothelin balance after nephron 13. Wascher et al. Effects of low-dose L-arginine on insulin-mediated vasodilation 14. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill:a |
| Copyright ©2010 Betty Clarke. All Rights Reserved. |